Exact Sciences Cor (EXAS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,491,288 | 806,678 | 703,926 | 701,054 | 177,254 |
| Marketable Securities | 348,699 | 476,324 | 518,731 | 530,062 | 146,401 |
| Receivables | 233,185 | 206,606 | 163,608 | 140,046 | 130,362 |
| Inventories | 92,265 | 80,427 | 82,215 | 69,424 | 61,724 |
| TOTAL | $2,198,594 | $1,606,627 | $1,504,858 | $1,484,318 | $553,936 |
| Non-Current Assets | |||||
| PPE Net | 451,986 | 456,455 | 463,437 | 465,476 | 455,325 |
| Intangibles | 2,084,795 | 2,109,332 | 2,342,787 | 2,365,422 | 2,346,747 |
| Other Non-Current Assets | 189,717 | 181,956 | 156,653 | 145,909 | 149,760 |
| TOTAL | $2,726,498 | $2,747,743 | $2,962,877 | $2,976,807 | $2,951,832 |
| Total Assets | $4,925,092 | $4,354,370 | $4,467,735 | $4,461,125 | $3,505,768 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 314,034 | 1,319 | 1,319 | 24,565 | 834 |
| Accounts payable and accrued liabilities | 35,709 | 26,061 | 30,998 | 38,048 | 25,973 |
| Accrued Expenses | 233,604 | 182,945 | 139,505 | 166,596 | 193,329 |
| Other current liabilities | 38,265 | 31,761 | 40,581 | 5,709 | 8,467 |
| TOTAL | $633,095 | $252,832 | $222,274 | $243,581 | $236,494 |
| Non-Current Liabilities | |||||
| Long Term Debt | 22,342 | 22,643 | 22,944 | N/A | 24,032 |
| Other Non-Current Liabilities | 2,034,102 | 1,741,795 | 1,711,324 | 1,679,891 | 957,181 |
| TOTAL | $2,056,444 | $1,764,438 | $1,734,268 | $1,679,891 | $981,213 |
| Total Liabilities | $2,689,539 | $2,017,270 | $1,956,542 | $1,923,472 | $1,217,707 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 169,093 | 150,424 | 150,167 | 149,746 | 147,968 |
| Common Shares | 1,595 | 1,505 | 1,501 | 1,495 | 1,477 |
| Retained earnings | -2,045,895 | -1,531,479 | -1,311,595 | -1,225,453 | -1,119,756 |
| Other shareholders' equity | 526 | 1,084 | 1,489 | -1,717 | -100 |
| TOTAL | $2,235,553 | $2,337,100 | $2,511,193 | $2,537,653 | $2,288,061 |
| Total Liabilities And Equity | $4,925,092 | $4,354,370 | $4,467,735 | $4,461,125 | $3,505,768 |